This company has been marked as potentially delisted and may not be actively trading. Spectrum Pharmaceuticals (SPPI) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock SPPI Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period ATTENTION NASDAQ: SPPI INVESTORS: Contact Berger Montague About a Spectrum Pharmaceuticals ...August 7 at 12:15 PM | gurufocus.comATTENTION NASDAQ: SPPI INVESTORS: Contact Berger Montague About a Spectrum Pharmaceuticals Class Action LawsuitAugust 7 at 11:46 AM | globenewswire.comBerger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. ...August 6 at 4:13 PM | gurufocus.comBerger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) InvestorsAugust 6 at 3:41 PM | prnewswire.comFilgotinib Shows Positive Topline Results Across Full Spectrum of Axial Spondyloarthritis in OLINGUITO Phase 3 StudyJuly 28, 2025 | businesswire.comIDMC Provides Positive Recommendation for Bio-Thera Solution's BAT4406F (ADCC-Enhanced Anti-CD20 mAb) in Neuromyelitis Optica Spectrum Disorder Based on Interim Analysis of Pivotal Phase II/III TrialJuly 2, 2025 | prnewswire.comPneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum AntiviralJuly 2, 2025 | globenewswire.comOsivax Announces Last Patient Last Visit in Phase 2a Trial Evaluating a Booster Dose of Broad-Spectrum Influenza Vaccine OVX836 s releaseJune 5, 2025 | globenewswire.comBio-Thera Solutions Publishes Phase I Clinical Study Results for BAT4406F, an ADCC-Enhanced Fully Humanized Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum DisordersJanuary 14, 2025 | prnewswire.comNon-Hodgkin’s Lymphoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and BarriersNovember 4, 2024 | theglobeandmail.comQylur Awarded SBIR Phase II Contract for a Tactical AI Spectrum Classifier Systems (TASCS)October 2, 2024 | globenewswire.comNanoViricides prepares for Phase II trial of broad-spectrum antiviral NV-387August 19, 2024 | proactiveinvestors.comSTALICLA publishes pioneering phase 1b data on precision treatment for autism spectrum disorder in BiomedicinesJune 27, 2024 | globenewswire.comOsivax Completes Enrollment for Phase 1 Trial with Broad-Spectrum Sarbecovirus Vaccine Candidate, OVX033June 25, 2024 | businesswire.comPneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 ConferenceMay 23, 2024 | globenewswire.comPneumagen to Present Phase 2 Clinical Data on Neumifil, its Broad-Spectrum Antiviral, Intranasal Drug for Viral Respiratory Tract Infections, at ATS 2024May 2, 2024 | globenewswire.comAssertio Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - ASRTFebruary 21, 2024 | markets.businessinsider.comLevi & Korsinsky Notifies Shareholders of Assertio Holdings, Inc.(ASRT) of a Class Action Lawsuit and an Upcoming DeadlineFebruary 21, 2024 | markets.businessinsider.comLost Money on Assertio Holdings, Inc.(ASRT)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyFebruary 8, 2024 | markets.businessinsider.comAssertio Holdings, Inc. (NASDAQ: ASRT) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class ActionFebruary 5, 2024 | markets.businessinsider.comGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Assertio Holdings, Inc. (ASRT)February 1, 2024 | stockhouse.comCLASS ACTION NOTICE: Berger Montague Encourages Assertio Holdings, Inc. (ASRT) Investors to Inquire About a Securities Fraud Class ActionFebruary 1, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Levi & Korsinsky Notifies Assertio Holdings, Inc.(ASRT) Investors of a Class Action Lawsuit and Upcoming DeadlineJanuary 30, 2024 | stockhouse.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Assertio Holdings, Inc. (ASRT) InvestorsJanuary 26, 2024 | tmcnet.comINVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Assertio Holdings, Inc.(ASRT) of a Class Action Lawsuit and an Upcoming DeadlineJanuary 13, 2024 | stockhouse.comEye Melanoma Market Size Worth USD 9.56 Billion in 2032 | Emergen ResearchJanuary 12, 2024 | finance.yahoo.comVaccine Adjuvant Market Size Worth USD 1.75 Billion in 2032 | Emergen ResearchJanuary 10, 2024 | finance.yahoo.comSHAREHOLDER ALERT: Potential Recovery for Assertio Holdings, Inc. (ASRT) InvestorsJanuary 9, 2024 | msn.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Assertio Holdings, Inc. - ASRTNovember 9, 2023 | markets.businessinsider.comSpectrum Pharmaceuticals (Nasdaq:SPPI) HeadlineTrading was temporarily halted for "SPPI" at 07:07 PM with a stated reason of "News pending."...August 1, 2023 | marketbeat.comBuy Spectrum Pharmaceuticals For Exposure To Assertio HoldingsJuly 24, 2023 | seekingalpha.comSpectrum Pharmaceuticals (NASDAQ:SPPI) Research Coverage Started at StockNews.comJuly 24, 2023 | marketbeat.comSpectrum Pharmaceuticals (NASDAQ: SPPI)July 8, 2023 | fool.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Receives Average Recommendation of "Hold" from AnalystsJuly 4, 2023 | marketbeat.comMoore Kuehn Encourages SYNH, SPPI, ARNC and EMBK Investors to Contact Law FirmJuly 3, 2023 | benzinga.comSPPI - Spectrum Pharmaceuticals, Inc.June 30, 2023 | finance.yahoo.comAre (More) Big Gains Ahead for This Small Cap Biotech Stock? (SPPI)With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.June 28, 2023 | marketbeat.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Given Average Rating of "Hold" by AnalystsJune 9, 2023 | marketbeat.comHC Wainwright Comments on Spectrum Pharmaceuticals, Inc.'s Q3 2023 Earnings (NASDAQ:SPPI)May 29, 2023 | marketbeat.comHC Wainwright & Co. Reiterates Spectrum Pharmaceuticals (SPPI) Neutral RecommendationMay 26, 2023 | msn.comSpectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Short Interest Down 49.2% in MayMay 26, 2023 | marketbeat.comSpectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementMay 17, 2023 | finance.yahoo.comJefferies Downgrades Spectrum Pharmaceuticals (SPPI)May 15, 2023 | msn.comNews Flash: Analysts Just Made A Captivating Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) ForecastsMay 14, 2023 | finance.yahoo.comQ1 2023 Assertio Holdings Inc Earnings CallMay 10, 2023 | finance.yahoo.comSpectrum Pharmaceuticals rises as co. says its Q1 net sales up 54% Q/QMay 9, 2023 | msn.comSpectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue EstimatesMay 9, 2023 | finance.yahoo.comB.Riley Financial Remains a Hold on Spectrum Pharmaceuticals (SPPI)May 5, 2023 | markets.businessinsider.comSHAREHOLDER ALERT: Weiss Law Reminds SPPI, NATI, CCFN, and ARST Shareholders About Its Ongoing InvestigationsMay 1, 2023 | benzinga.comLifshitz Law PLLC Announces Investigations of HOTH, ASRT, SPPI, and CEIApril 30, 2023 | benzinga.com Get Spectrum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SPPI and its competitors with MarketBeat's FREE daily newsletter. Email Address SPPI Media Mentions By Week SPPI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SPPI News Sentiment▼0.000.38▲Average Medical News Sentiment SPPI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SPPI Articles This Week▼40▲SPPI Articles Average Week Get Spectrum Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SPPI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GERN News ZBIO News RIGL News LXRX News MYGN News XOMA News VSTM News EBS News VNDA News CDXS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SPPI) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectrum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectrum Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SPPI Stock Alerts